579 related articles for article (PubMed ID: 26822915)
1. Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitis.
Balázs A; Hegyi P; Sahin-Tóth M
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G477-86. PubMed ID: 26822915
[TBL] [Abstract][Full Text] [Related]
2. Functional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis.
Schnúr A; Beer S; Witt H; Hegyi P; Sahin-Tóth M
Gut; 2014 Feb; 63(2):337-43. PubMed ID: 23455445
[TBL] [Abstract][Full Text] [Related]
3. Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis.
Németh BC; Sahin-Tóth M
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G466-73. PubMed ID: 24458023
[TBL] [Abstract][Full Text] [Related]
4. Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis.
Szabó A; Ludwig M; Hegyi E; Szépeová R; Witt H; Sahin-Tóth M
J Biol Chem; 2015 Jul; 290(28):17282-92. PubMed ID: 26013824
[TBL] [Abstract][Full Text] [Related]
5. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.
Szabó A; Sahin-Tóth M
J Biol Chem; 2012 Jun; 287(24):20701-10. PubMed ID: 22539344
[TBL] [Abstract][Full Text] [Related]
6. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
7. Novel Pathogenic
Jancsó Z; Oracz G; Kujko AA; Kolodziejczyk E; Radisky ES; Rygiel AM; Sahin-Tóth M
Front Genet; 2019; 10():46. PubMed ID: 30792736
[TBL] [Abstract][Full Text] [Related]
8. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
Chandak GR; Idris MM; Reddy DN; Mani KR; Bhaskar S; Rao GV; Singh L
Gut; 2004 May; 53(5):723-8. PubMed ID: 15082592
[TBL] [Abstract][Full Text] [Related]
9. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
Jancsó Z; Sahin-Tóth M
J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of cationic trypsinogen (PRSS1) and serine protease inhibitor, Kazal type 1 (SPINK1) gene mutations in Polish patients with alcoholic and idiopathic chronic pancreatitis.
Gasiorowska A; Talar-Wojnarowska R; Czupryniak L; Smolarz B; Romanowicz-Makowska H; Kulig A; Malecka-Panas E
Dig Dis Sci; 2011 Mar; 56(3):894-901. PubMed ID: 20676769
[TBL] [Abstract][Full Text] [Related]
11. PRSS1 and SPINK1 mutations in idiopathic chronic and recurrent acute pancreatitis.
Pelaez-Luna M; Robles-Diaz G; Canizales-Quinteros S; Tusié-Luna MT
World J Gastroenterol; 2014 Sep; 20(33):11788-92. PubMed ID: 25206283
[TBL] [Abstract][Full Text] [Related]
12. Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.
Geisz A; Hegyi P; Sahin-Tóth M
FEBS J; 2013 Jun; 280(12):2888-99. PubMed ID: 23601753
[TBL] [Abstract][Full Text] [Related]
13. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site.
Felderbauer P; Schnekenburger J; Lebert R; Bulut K; Parry M; Meister T; Schick V; Schmitz F; Domschke W; Schmidt WE
J Med Genet; 2008 Aug; 45(8):507-12. PubMed ID: 18511571
[TBL] [Abstract][Full Text] [Related]
14. Mutation That Promotes Activation of Trypsinogen Increases Severity of Secretagogue-Induced Pancreatitis in Mice.
Jancsó Z; Sahin-Tóth M
Gastroenterology; 2020 Mar; 158(4):1083-1094. PubMed ID: 31751559
[TBL] [Abstract][Full Text] [Related]
15. Gene conversion between cationic trypsinogen (PRSS1) and the pseudogene trypsinogen 6 (PRSS3P2) in patients with chronic pancreatitis.
Rygiel AM; Beer S; Simon P; Wertheim-Tysarowska K; Oracz G; Kucharzik T; Tysarowski A; Niepokój K; Kierkus J; Jurek M; Gawliński P; Poznański J; Bal J; Lerch MM; Sahin-Tóth M; Weiss FU
Hum Mutat; 2015 Mar; 36(3):350-6. PubMed ID: 25546417
[TBL] [Abstract][Full Text] [Related]
16. Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.
Joergensen MT; Geisz A; Brusgaard K; Schaffalitzky de Muckadell OB; Hegyi P; Gerdes AM; Sahin-Tóth M
Pancreas; 2011 May; 40(4):540-6. PubMed ID: 21499207
[TBL] [Abstract][Full Text] [Related]
17. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism.
Kereszturi E; Szmola R; Kukor Z; Simon P; Weiss FU; Lerch MM; Sahin-Tóth M
Hum Mutat; 2009 Apr; 30(4):575-82. PubMed ID: 19191323
[TBL] [Abstract][Full Text] [Related]
18. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.
Drenth JP; te Morsche R; Jansen JB
Gut; 2002 May; 50(5):687-92. PubMed ID: 11950817
[TBL] [Abstract][Full Text] [Related]
19. Hereditary chronic pancreatitis.
Rosendahl J; Bödeker H; Mössner J; Teich N
Orphanet J Rare Dis; 2007 Jan; 2():1. PubMed ID: 17204147
[TBL] [Abstract][Full Text] [Related]
20. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen.
Simon P; Weiss FU; Sahin-Toth M; Parry M; Nayler O; Lenfers B; Schnekenburger J; Mayerle J; Domschke W; Lerch MM
J Biol Chem; 2002 Feb; 277(7):5404-10. PubMed ID: 11719509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
